We are live on
!
Find out more
EUCRU
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
EUCRU
Delisted
EUCRU was delisted on the 26th of April, 2023.
14 hedge funds and large institutions have $27.1M invested in Eucrates Biomedical Acquisition Corp. Unit in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
18% less funds holding
Funds holding: 17 → 14 (-3)
34% less capital invested
Capital invested by funds: $41.2M → $27.1M (-$14.1M)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Holders
14
Holders Change
-3
Holders Change %
-17.65%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$9.95M |
| 2 |
HM
HealthCor Management
New York
|
-$2.32M |
| 3 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$2.05M |
| 4 |
GCL
Glazer Capital LLC
New York
|
-$791K |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$40.2K |